Advances in Programmed Cell Death Research in Intervertebral Disc Degeneration

Authors

  • Yong Tan
  • Dongping Ye

DOI:

https://doi.org/10.54097/914qqr67

Keywords:

Intervertebral Disc Degeneration, Programmed Cell Death, PANoptosis, Apoptosis, Pyroptosis, Necroptosis, Ferroptosis

Abstract

One of the primary causes of chronic low back pain and functional impairment is intervertebral disc degeneration. Various modes of programmed cell death such as apoptosis, pyroptosis, necroptosis, and ferroptosis and novel modes such as cupric death, disulfide bond death, and alkaline death contribute to the progressive loss of cells in the nucleus pulposus intervertebral discs and the establishment of an inflammatory microenvironment. Holistic processes such as PANoptosis reveal that programmed cell death is not mutually exclusive. The setting out of programmed cell death and intervertebral disc degeneration is also coordinately governed by upstream stimulus transduction. Recent technological breakthroughs in genome editing tools, individual cell transcriptomics, and biomaterials have not only deepened our understanding of programmed cell death pathways but have also opened novel avenues of intervertebral disc therapy. Targeting multiple modes of programmed cell death seems to have a greater advantage with regard to restoring the homeostatic balance of intervertebral discs to their original state. Nonetheless, there still remain matters related to precise intradiscal target delivery, human-scale modeling, and dynamic monitoring. Noting the elaborate programmed cell death network provides a theoretical framework for designing novel intervertebral disc precision medicine.

Downloads

Download data is not yet available.

References

[1] L. Kang, H. Zhang, C. Jia, R. Zhang, and C. Shen, “Epigenetic modifications of inflammation in intervertebral disc degeneration.,” Ageing Res Rev, vol. 87, p. 101902, June 2023, doi: 10.1016/j.arr.2023.101902.

[2] G. Cao et al., “The Role of Oxidative Stress in Intervertebral Disc Degeneration.,” Oxid Med Cell Longev, vol. 2022, p. 2166817, 2022, doi: 10.1155/2022/2166817.

[3] B. Qiu, X. Xie, and Y. Xi, “Mitochondrial quality control: the real dawn of intervertebral disc degeneration?,” J Transl Med, vol. 22, no. 1, p. 1126, Dec. 2024, doi: 10.1186/s12967-024-05943-9.

[4] F. Yang et al., “S100A6 Regulates nucleus pulposus cell apoptosis via Wnt/beta-catenin signaling pathway: an in vitro and in vivo study.,” Mol Med, vol. 30, no. 1, p. 87, June 2024, doi: 10.1186/s10020-024-00853-4.

[5] Z. Liu et al., “Biomaterial-based treatments for structural reconstruction in intervertebral disc degeneration.,” Biomaterials, vol. 324, p. 123426, Jan. 2026, doi: 10.1016/j. biomaterials. 2025.123426.

[6] R. He et al., “HIF1A Alleviates compression-induced apoptosis of nucleus pulposus derived stem cells via upregulating autophagy.,” Autophagy, vol. 17, no. 11, pp. 3338–3360, Nov. 2021, doi: 10.1080/15548627.2021.1872227.

[7] X. Lu et al., “Sulforaphane Delays Intervertebral Disc Degeneration by Alleviating Endoplasmic Reticulum Stress in Nucleus Pulposus Cells via Activating Nrf-2/HO-1.,” Oxid Med Cell Longev, vol. 2023, p. 3626091, 2023, doi: 10. 1155/ 2023/3626091.

[8] F. Yang et al., “Regulated cell death: Implications for intervertebral disc degeneration and therapy.,” J Orthop Translat, vol. 37, pp. 163–172, Nov. 2022, doi: 10.1016/j. jot. 2022. 10.009.

[9] S. Li et al., “Natural products targeting programmed cell death: a novel therapeutic strategy for intervertebral disc degeneration.,” Int J Surg, Oct. 2025, doi: 10.1097/JS9. 0000 000000003380.

[10] J. Chen et al., “Targeting Ferroptosis Holds Potential for Intervertebral Disc Degeneration Therapy.,” Cells, vol. 11, no. 21, Nov. 2022, doi: 10.3390/cells11213508.

[11] J. Yan et al., “miR-328-5p Induces Human Intervertebral Disc Degeneration by Targeting WWP2.,” Oxid Med Cell Longev, vol. 2022, p. 3511967, 2022, doi: 10.1155/2022/3511967.

[12] H. Lin et al., “Reactive Oxygen Species Regulate Endoplasmic Reticulum Stress and ER-Mitochondrial Ca(2+) Crosstalk to Promote Programmed Necrosis of Rat Nucleus Pulposus Cells under Compression.,” Oxid Med Cell Longev, vol. 2021, p. 8810698, 2021, doi: 10.1155/2021/8810698.

[13] Y. Lv et al., “Machine learning-based analysis of programmed cell death types and key genes in intervertebral disc degeneration.,” Apoptosis, vol. 30, no. 1–2, pp. 250–266, Feb. 2025, doi: 10.1007/s10495-024-02047-z.

[14] Y. Dou et al., “Role of macrophage in intervertebral disc degeneration.,” Bone Res, vol. 13, no. 1, p. 15, Jan. 2025, doi: 10.1038/s41413-024-00397-7.

[15] S. Qiao et al., “RIPK1-RIPK3 mediates myocardial fibrosis in type 2 diabetes mellitus by impairing autophagic flux of cardiac fibroblasts,” Cell Death Dis, vol. 13, no. 2, p. 147, Feb. 2022, doi: 10.1038/s41419-022-04587-1.

[16] X. Huang et al., “AIM2 activation mediated by RIPK1/3-dependent mitochondrial DNA release drives Aβ1-40-Induced retinal pigment epithelium injury,” Cell Commun Signal, vol. 23, no. 1, p. 301, June 2025, doi: 10.1186/s12964-025-02294-w.

[17] Z. Zhu et al., “RIPK1-targeted therapy alleviates intervertebral disc degeneration via inhibiting nucleus pulposus PANoptosis,” Apoptosis, Sept. 2025, doi: 10.1007/s10495-025-02169-y.

[18] “Microenvironment Remodeling Microgel Repairs Degenerated Intervertebral Disc via Programmed Delivery of MicroRNA-155 - PubMed.” Accessed: Nov. 06, 2025. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/39804788/

[19] W. Lan et al., “A pH/ROS dual responsive smart microgel miRNA delivery system for repair of intervertebral disc degeneration,” J Mater Chem B, vol. 13, no. 36, pp. 11454–11469, Sept. 2025, doi: 10.1039/d5tb01505g.

[20] J. Zhang et al., “Hydrogel delivery systems in intervertebral disc degeneration: Current status and future perspectives.,” J Control Release, vol. 386, p. 114066, Oct. 2025, doi: 10.1016/j.jconrel.2025.114066.

[21] H. Zhong et al., “The miR-623/CXCL12 axis inhibits LPS-induced nucleus pulposus cell apoptosis and senescence,” Mech Ageing Dev, vol. 194, p. 111417, Mar. 2021, doi: 10.1016/j.mad.2020.111417.

[22] N. Prathumsap et al., “Vagus nerve stimulation exerts cardioprotection against doxorubicin-induced cardiotoxicity through inhibition of programmed cell death pathways.,” Cell Mol Life Sci, vol. 80, no. 1, p. 21, Dec. 2022, doi: 10.1007/s00018-022-04678-4.

[23] J.-L. Huo, S. Wang, X.-H. Yuan, B. Yu, W. Zhao, and H.-M. Liu, “Discovery of [1,2,4]triazolo[1,5-a]pyrimidines derivatives as potential anticancer agents,” Eur J Med Chem, vol. 211, p. 113108, Feb. 2021, doi: 10.1016/j. ejmech. 2020. 113108.

[24] Ł. Kopiasz, K. Dziendzikowska, M. Oczkowski, J. Harasym, and J. Gromadzka-Ostrowska, “Low-molar-mass oat beta-glucan impacts autophagy and apoptosis in early stages of induced colorectal carcinogenesis in rats,” Int J Biol Macromol, vol. 254, no. Pt 2, p. 127832, Jan. 2024, doi: 10.1016/j. ijbiomac. 2023.127832.

[25] Z.-N. Huang et al., “Melatonin alleviates oxidative stress-induced injury to nucleus pulposus-derived mesenchymal stem cells through activating PI3K/Akt pathway,” J Orthop Translat, vol. 43, pp. 66–84, Nov. 2023, doi: 10.1016/j.jot.2023.10.002.

[26] G.-Z. Zhang et al., “NF-kappaB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration.,” Cell Prolif, vol. 54, no. 7, p. e13057, July 2021, doi: 10.1111/ cpr.13057.

[27] J. Lin et al., “DBC1 promotes intervertebral disc degeneration by activating NF-κB pathway and inhibiting SIRT1 activity,” Life Sci, vol. 373, p. 123689, July 2025, doi: 10.1016/j. lfs. 2025.123689.

[28] Z. Liao et al., “Autophagic Degradation of Gasdermin D Protects against Nucleus Pulposus Cell Pyroptosis and Retards Intervertebral Disc Degeneration In Vivo.,” Oxid Med Cell Longev, vol. 2021, p. 5584447, 2021, doi: 10.1155/ 2021/ 5584447.

[29] G. Tang et al., “Propionibacterium acnes Accelerates Intervertebral Disc Degeneration by Inducing Pyroptosis of Nucleus Pulposus Cells via the ROS-NLRP3 Pathway.,” Oxid Med Cell Longev, vol. 2021, p. 4657014, 2021, doi: 10.1155/ 2021/4657014.

[30] S. Gao et al., “Mechanism of glycolysis-pyrolysis crosstalk driving vicious circle of intervertebral disc degeneration.,” Apoptosis, Oct. 2025, doi: 10.1007/s10495-025-02194-x.

[31] D. Wang et al., “A natural hydrogel complex improves intervertebral disc degeneration by correcting fatty acid metabolism and inhibiting nucleus pulposus cell pyroptosis.,” Mater Today Bio, vol. 26, p. 101081, June 2024, doi: 10.1016/j.mtbio.2024.101081.

[32] H. Xing et al., “Engineered Cell Membrane-Coated Keratin Nanoparticles Attenuated Intervertebral Disc Degeneration by Remodeling the Disc Microenvironment,” Adv Healthc Mater, vol. 14, no. 6, p. e2404173, Mar. 2025, doi: 10.1002/ adhm. 202404173.

[33] S. W. Ryter, “Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.,” Cells, vol. 10, no. 3, Feb. 2021, doi: 10.3390/cells10030515.

[34] S. Lu et al., “Ferroportin-Dependent Iron Homeostasis Protects against Oxidative Stress-Induced Nucleus Pulposus Cell Ferroptosis and Ameliorates Intervertebral Disc Degeneration In Vivo.,” Oxid Med Cell Longev, vol. 2021, p. 6670497, 2021, doi: 10.1155/2021/6670497.

[35] J. Zhu et al., “The deubiquitinase USP11 ameliorates intervertebral disc degeneration by regulating oxidative stress-induced ferroptosis via deubiquitinating and stabilizing Sirt3.,” Redox Biol, vol. 62, p. 102707, June 2023, doi: 10.1016/j. redox.2023.102707.

[36] P. Zhang et al., “Cynarin alleviates intervertebral disc degeneration via protecting nucleus pulposus cells from ferroptosis.,” Biomed Pharmacother, vol. 165, p. 115252, Sept. 2023, doi: 10.1016/j.biopha.2023.115252.

[37] J. Guo, Y. Yang, J. Niu, Z. Luo, Q. Shi, and H. Yang, “Establishment of Ferroptosis-Related Key Gene Signature and Its Validation in Compression-Induced Intervertebral Disc Degeneration Rats.,” Oxid Med Cell Longev, vol. 2023, p. 9020236, 2023, doi: 10.1155/2023/9020236.

[38] H. Wang et al., “Oxidative stress activates YAP/TEAD1/NCOA4 axis to promote ferroptosis of endplate chondrocytes and aggravate intervertebral disc degeneration.,” J Orthop Translat, vol. 54, pp. 8–25, Sept. 2025, doi: 10.1016/ j.jot.2025.07.001.

[39] Y. Li et al., “Silencing ATF3 Might Delay TBHP-Induced Intervertebral Disc Degeneration by Repressing NPC Ferroptosis, Apoptosis, and ECM Degradation.,” Oxid Med Cell Longev, vol. 2022, p. 4235126, 2022, doi: 10.1155/ 2022/ 4235126.

[40] L. Chen, J. Min, and F. Wang, “Copper homeostasis and cuproptosis in health and disease,” Signal Transduct Target Ther, vol. 7, no. 1, p. 378, Nov. 2022, doi: 10.1038/s41392-022-01229-y.

[41] H. Zhi et al., “Lactate metabolism regulating nanosystem synergizes cuproptosis and ferroptosis to enhance cancer immunotherapy,” Biomaterials, vol. 325, p. 123538, Feb. 2026, doi: 10.1016/j.biomaterials.2025.123538.

[42] N. Liu and M. Chen, “Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application,” Biomed Pharmacother, vol. 171, p. 116115, Feb. 2024, doi: 10.1016/j.biopha.2023.116115.

[43] Z. Tian, S. Jiang, J. Zhou, and W. Zhang, “Copper homeostasis and cuproptosis in mitochondria,” Life Sci, vol. 334, p. 122223, Dec. 2023, doi: 10.1016/j.lfs.2023.122223.

[44] Z. Guo et al., “Injectable Nanocomposite Hydrogels for Intervertebral Disc Degeneration: Combating Oxidative Stress, Mitochondrial Dysfunction, and Ferroptosis,” Adv Healthc Mater, vol. 14, no. 11, p. e2403892, Apr. 2025, doi: 10.1002/ adhm. 202403892.

[45] Z. Xiang et al., “Cuproptosis and its potential role in musculoskeletal disease,” Front Cell Dev Biol, vol. 13, p. 1570131, 2025, doi: 10.3389/fcell.2025.1570131.

[46] Z. Liu et al., “PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.,” Apoptosis, vol. 29, no. 5–6, pp. 799–815, June 2024, doi: 10.1007/s10495-023-01931-4.

[47] C. Guo et al., “Microenvironment Remodeling Microgel Repairs Degenerated Intervertebral Disc via Programmed Delivery of MicroRNA-155,” ACS Appl Mater Interfaces, vol. 17, no. 4, pp. 6009–6023, Jan. 2025, doi: 10.1021/ acsami. 4c18 801.

[48] P.-B. Chen et al., “Oxidative Stress Aggravates Apoptosis of Nucleus Pulposus Cells through m6A Modification of MAT2A Pre-mRNA by METTL16,” Oxid Med Cell Longev, vol. 2022, p. 4036274, 2022, doi: 10.1155/2022/4036274.

[49] K. Zhou et al., “Exploring the critical role of PANoptosis in the pathogenesis of intervertebral disc degeneration: mechanisms and potential therapeutic targets,” Front Cell Dev Biol, vol. 13, p. 1611936, 2025, doi: 10.3389/fcell.2025.1611936.

[50] S. Yang et al., “Screening of NSAIDs library identifies Tinoridine as a novel ferroptosis inhibitor for potential intervertebral disc degeneration therapy.,” Free Radic Biol Med, vol. 221, pp. 245–256, Aug. 2024, doi: 10.1016/j. freeradbiomed.2024.05.040.

[51] S. Wu et al., “Glucose deprivation-induced disulfidptosis in human nucleus pulposus cells: a novel pathological mechanism of intervertebral disc degeneration.,” Biol Direct, vol. 19, no. 1, p. 81, Sept. 2024, doi: 10.1186/s13062-024-00528-4.

[52] X. Zhao et al., “Bidirectional Regulatory Mechanisms of Disulfidptosis Govern Precision Targeting in Degenerative Bone Diseases and Osteosarcoma,” J Cell Physiol, vol. 240, no. 10, p. e70100, Oct. 2025, doi: 10.1002/jcp.70100.

[53] X. Liu et al., “Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis,” Nat Cell Biol, vol. 25, no. 3, pp. 404–414, Mar. 2023, doi: 10.1038/s41556-023-01091-2.

[54] Y. Guo et al., “Acid-sensing ion channels mediate the degeneration of intervertebral disc via various pathways-A systematic review,” Channels (Austin), vol. 13, no. 1, pp. 367–373, Dec. 2019, doi: 10.1080/19336950.2019.1664038.

[55] S. Jia et al., “Single-cell sequencing reveals cellular heterogeneity of nucleus pulposus in intervertebral disc degeneration,” Sci Rep, vol. 14, no. 1, p. 27245, Nov. 2024, doi: 10.1038/s41598-024-78675-x.

[56] X.-J. Yu et al., “Deciphering SPP1-related macrophage signaling in the pathogenesis of intervertebral disc degeneration.,” Cell Biol Toxicol, vol. 41, no. 1, p. 33, Jan. 2025, doi: 10.1007/s10565-024-09948-4.

[57] X. Chen et al., “The role of oxidative stress in intervertebral disc degeneration: Mechanisms and therapeutic implications.,” Ageing Res Rev, vol. 98, p. 102323, July 2024, doi: 10.1016/j.arr.2024.102323.

[58] B. Wang et al., “Mechanosensitive Ion Channel Piezo1 Activated by Matrix Stiffness Regulates Oxidative Stress-Induced Senescence and Apoptosis in Human Intervertebral Disc Degeneration.,” Oxid Med Cell Longev, vol. 2021, p. 8884922, 2021, doi: 10.1155/2021/8884922.

[59] Y. Zhuo et al., “SIRT1 Attenuates Apoptosis of Nucleus Pulposus Cells by Targeting Interactions between LC3B and Fas under High-Magnitude Compression.,” Oxid Med Cell Longev, vol. 2021, p. 2420969, 2021, doi: 10.1155/ 2021/ 2420 969.

[60] Z.-R. Dong et al., “Ciliary IFT88 inhibits intervertebral disc degeneration under excessive mechanical stress by regulating endplate cartilage calcification.,” J Adv Res, pp. S2090-1232(25)00360–1, May 2025, doi: 10.1016/j.jare.2025.05.042.

[61] W. Ke et al., “The distinct roles of myosin IIA and IIB under compression stress in nucleus pulposus cells.,” Cell Prolif, vol. 54, no. 2, p. e12987, Feb. 2021, doi: 10.1111/cpr.12987.

[62] W. Ke et al., “An overview of mechanical microenvironment and mechanotransduction in intervertebral disc degeneration.,” Exp Mol Med, vol. 57, no. 10, pp. 2157–2168, Oct. 2025, doi: 10.1038/s12276-025-01546-6.

[63] D. Wang et al., “Phosphorylation of KRT8 (keratin 8) by excessive mechanical load-activated PKN (protein kinase N) impairs autophagosome initiation and contributes to disc degeneration.,” Autophagy, vol. 19, no. 9, pp. 2485–2503, Sept. 2023, doi: 10.1080/15548627.2023.2186099.

[64] W. Xie et al., “Intervertebral Disc-on-a-ChipMF: A New Model for Mouse Disc Culture via Integrating Mechanical Loading and Dynamic Media Flow,” Adv Mater Technol, vol. 8, no. 21, p. 2300606, Nov. 2023, doi: 10.1002/admt. 20230 06 06.

[65] C. Jia et al., “Selenium-SelK-GPX4 axis protects nucleus pulposus cells against mechanical overloading-induced ferroptosis and attenuates senescence of intervertebral disc.,” Cell Mol Life Sci, vol. 81, no. 1, p. 49, Jan. 2024, doi: 10.1007/s00018-023-05067-1.

[66] J. Wu et al., “Self-amplifying loop of NF-kappaB and periostin initiated by PIEZO1 accelerates mechano-induced senescence of nucleus pulposus cells and intervertebral disc degeneration.,” Mol Ther, vol. 30, no. 10, pp. 3241–3256, Oct. 2022, doi: 10.1016/j.ymthe.2022.05.021.

[67] C. Guo, Y. Liu, Z. Zhao, Y. Wu, Q. Kong, and Y. Wang, “Regulating inflammation and apoptosis: A smart microgel gene delivery system for repairing degenerative nucleus pulposus.,” J Control Release, vol. 365, pp. 1004–1018, Jan. 2024, doi: 10.1016/j.jconrel.2023.12.029.

[68] Y.-T. Chuang et al., “The modulation of immune cell death in connection to microRNAs and natural products,” Front Immunol, vol. 15, p. 1425602, 2024, doi: 10.3389/fimmu. 2024. 1425602.

[69] H. Levis et al., “Targeted CRISPR regulation of ZNF865 enhances stem cell cartilage deposition, tissue maturation rates, and mechanical properties in engineered intervertebral discs.,” Acta Biomater, vol. 191, pp. 276–291, Jan. 2025, doi: 10.1016/j.actbio.2024.11.007.

[70] W. Chen et al., “Dual-pathological cascade delivery of apoptotic vesicles for targeted therapy in intervertebral disc degeneration.,” Mater Today Bio, vol. 34, p. 102200, Oct. 2025, doi: 10.1016/j.mtbio.2025.102200.

[71] S. Chen, Y. Dou, Y. Zhang, X. Sun, X. Liu, and Q. Yang, “Innovating intervertebral disc degeneration therapy: Harnessing the power of extracellular vesicles.,” J Orthop Translat, vol. 50, pp. 44–55, Jan. 2025, doi: 10.1016/j.j ot.2024.09.014.

[72] Y. Wang et al., “Spheroid Formation Enhances the Regenerative Capacity of Nucleus Pulposus Cells via Regulating N-CDH and ITGbeta1 Interaction.,” Int J Biol Sci, vol. 18, no. 9, pp. 3676–3696, 2022, doi: 10.7150/ijbs.70903.

[73] H. Jiang, A. Moro, J. Wang, D. Meng, X. Zhan, and Q. Wei, “MicroRNA-338-3p as a novel therapeutic target for intervertebral disc degeneration.,” Exp Mol Med, vol. 53, no. 9, pp. 1356–1365, Sept. 2021, doi: 10.1038/s12276-021-00662-3.

[74] Z. Krut, G. Pelled, D. Gazit, and Z. Gazit, “Stem Cells and Exosomes: New Therapies for Intervertebral Disc Degeneration.,” Cells, vol. 10, no. 9, Aug. 2021, doi: 10.3390/ cells10092241.

[75] F. Chen et al., “Serglycin secreted by late-stage nucleus pulposus cells is a biomarker of intervertebral disc degeneration.,” Nat Commun, vol. 15, no. 1, p. 47, Jan. 2024, doi: 10.1038/s41467-023-44313-9.

[76] P. Cazzanelli et al., “The role of miR-155-5p in inflammation and mechanical loading during intervertebral disc degeneration.,” Cell Commun Signal, vol. 22, no. 1, p. 419, Aug. 2024, doi: 10.1186/s12964-024-01803-7.

[77] K. Sun et al., “Catalytic Nanodots-Driven Pyroptosis Suppression in Nucleus Pulposus for Antioxidant Intervention of Intervertebral Disc Degeneration.,” Adv Mater, vol. 36, no. 19, p. e2313248, May 2024, doi: 10.1002/adma.202313248.

[78] C. Chen et al., “Exosomes inhibit ferroptosis to alleviate intervertebral disc degeneration via the p62-KEAP1-NRF2 pathway.,” Free Radic Biol Med, vol. 232, pp. 171–184, May 2025, doi: 10.1016/j.freeradbiomed.2025.02.027.

[79] H. Zhou et al., “Microenvironment-responsive metal-phenolic network release platform with ROS scavenging, anti-pyroptosis, and ECM regeneration for intervertebral disc degeneration.,” Bioact Mater, vol. 37, pp. 51–71, July 2024, doi: 10.1016/j.bioactmat.2024.02.036.

[80] T. Zhang et al., “Biomimetic Microchannel Integrated Silk Fibroin Scaffold for Regeneration of Intervertebral Disc Degeneration.,” Biomater Res, vol. 29, p. 0203, 2025, doi: 10.34133/bmr.0203.

Downloads

Published

27-11-2025

Issue

Section

Articles

How to Cite

Tan, Y., & Ye, D. (2025). Advances in Programmed Cell Death Research in Intervertebral Disc Degeneration. International Journal of Biology and Life Sciences, 12(3), 41-48. https://doi.org/10.54097/914qqr67